Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Non-Current Assets (2016 - 2026)

Bioceres Crop Solutions' Non-Current Assets history spans 11 years, with the latest figure at $268.9 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets changed N/A to $268.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $268.9 million, a N/A change, with the full-year FY2025 number at $455.3 million, up 2.57% from a year prior.
  • Non-Current Assets hit $268.9 million in Q1 2026 for Bioceres Crop Solutions, down from $455.3 million in the prior quarter.
  • Over the last five years, Non-Current Assets for BIOX hit a ceiling of $455.3 million in Q2 2025 and a floor of $220.5 million in Q2 2022.
  • Historically, Non-Current Assets has averaged $361.9 million across 5 years, with a median of $420.9 million in 2023.
  • Biggest five-year swings in Non-Current Assets: soared 90.89% in 2023 and later rose 2.57% in 2025.
  • Tracing BIOX's Non-Current Assets over 5 years: stood at $220.5 million in 2022, then skyrocketed by 90.89% to $420.9 million in 2023, then rose by 5.45% to $443.9 million in 2024, then rose by 2.57% to $455.3 million in 2025, then plummeted by 40.94% to $268.9 million in 2026.
  • Business Quant data shows Non-Current Assets for BIOX at $268.9 million in Q1 2026, $455.3 million in Q2 2025, and $443.9 million in Q2 2024.